1 Hartwig J, Krämer H. 50 Jahre Baumol’sche Kostenkrankheit. Wirtschaftsdienst. 2017;97(11):793–800.
2 Baumol WJ. Macroeconomics of unbalanced growth. The anatomy of urban crisis. American Economic Review. 1967;57(3):415–26.
3 Vandermeulen A. A remission from Baumol’s Disease: Ways to publish more articles. Southern Economic Journal. 1968;35(2):189–91.
4 Baumol WJ, Bowen WG. On the performing arts: the anatomy
of their economic problems. American Economic Review. 1965;55
(1–2):495–502.
5 International Monetary Fund. Uneven growth: Short- and long-term factors. Washington DC; 2015.
6 Baumol WJ. The Cost Disease. Why Computers Get Cheaper and Health Care Doesn’t. New Haven CT; 2012.
7 Schettkat R, Yocarini L. The shift to services employment. A review of the literature. Structural Change and Economic Dynamics. 212;17(2): 127–47.
8 Hartwig J. Sind unsere gesamtwirtschaftlichen Probleme überhaupt lösbar? KOF Working Paper 112. Zurich (
https://doi.org/10.3929/ethz-a-005104863); 2005.
9 Hartwig J. What drives health care expenditure? Baumol’s model of «unbalanced growth» revisited. KOF Working Paper 133. Zurich (
https://doi.org/10.3929/ethz-a-005187505); 2006.
10 Hartwig J. Can Baumol’s model of unbalanced growth contribute to explaining the secular rise in health care expenditure? An alternative test. KOF Working Paper 178. Zurich (
https://doi.org/10.3929/ethz-a-005502972); 2007.
11 Hartwig J. What drives health care expenditure? – Baumol’s model of ‘unbalanced growth’ revisited. Journal of Health Economics. 2008;27(3):603–23.
12 Hartwig J. Can Baumol’s model of unbalanced growth contribute to explaining the secular rise in health care expenditure? An alternative test. Applied Economics. 2010;43(2):173–84.
13 Hartwig J, Sandqvist P. Ein Modell zur Prognose der schweizerischen Gesundheitsausgaben. KOF Analysen. 2015;9(3):109–25.
14 Colombier C. Ausgabenprojektionen für das Gesundheitswesen bis 2060. Working Paper der Eidgenössischen Finanzverwaltung Nr. 19. Bern; 2012.
15 Colombier C. Unwanted side effects of Baumol’s cost disease on a balanced-budget rule. mimeo; 2017.